Retinal Biologics Market Size, Share, And Growth Report 2032
Retinal Biologics Market By Drug Class (TNF-a Inhibitor and VEGF-A Antagonist), By Indication (Diabetic Retinopathy, Macular Degeneration, Uveitis, Diabetic Macular Edema, and Others), by Distribution Channel (Retail Sales and Institutional Sales), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 24.79 Billion | USD 49.56 Billion | 8.00% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Retinal Biologics Market, 2017-2025 (USD Million)
- 2.2. Global Retinal Biologics Market: Snapshot
- Chapter 3. Global Retinal Biologics Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing prevalence of retinal disorders
- 3.2.2. Technical advancement for ophthalmic drugs
- 3.2.3. Rising Geriatric Population
- 3.2.4. Favorable reimbursement policies in developed regions
- 3.3. Market Restraints
- 3.3.1. Introduction to alternate therapies
- 3.3.2. High Treatment Cost
- 3.4. Opportunities
- 3.4.1. Strategic alliances formed by the market players
- 3.4.2. Increasing awareness about the latest development
- 3.4.3. Opportunity from developing regions
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis, by Drug Class
- 3.6.2. Market attractiveness analysis, by Indication
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Retinal Biologics Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Retinal Biologics Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New therapy launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Retinal Biologics Market - Drug Class Analysis
- 5.1. Global Retinal Biologics Market: Drug Class overview
- 5.1.1. Global Retinal Biologics Market Revenue, by Drug Class, 2018 and 2025
- 5.2. TNF-α inhibitor
- 5.2.1. Global Retinal Biologics market for TNF-α inhibitor, 2017-2025 (USD Million)
- 5.3. VEGF-A antagonist
- 5.3.1. Global Retinal Biologics market for VEGF-A antagonist, 2017-2025 (USD Million)
- 5.1. Global Retinal Biologics Market: Drug Class overview
- Chapter 6. Global Retinal Biologics Market - Indication Analysis
- 6.1. Global Retinal Biologics Market: Indication overview
- 6.1.1. Global Retinal Biologics Market Revenue, by Indication, 2018 and 2025
- 6.2. Diabetic Retinopathy
- 6.2.1. Global Retinal Biologics market for Diabetic Retinopathy, 2017-2025 (USD Million)
- 6.3. Macular Degeneration
- 6.3.1. Global Retinal Biologics market for Macular Degeneration, 2017-2025 (USD Million)
- 6.4. Uveitis
- 6.4.1. Global Retinal Biologics market for Uveitis, 2017-2025 (USD Million)
- 6.5. Diabetic Macular Edema
- 6.5.1. Global Retinal Biologics market for Diabetic Macular Edema, 2017-2025 (USD Million)
- 6.6. Others
- 6.6.1. Global Retinal Biologics market for Others, 2017-2025 (USD Million)
- 6.1. Global Retinal Biologics Market: Indication overview
- Chapter 7. Global Retinal Biologics Market - Distribution Channel Analysis
- 7.1. Global Retinal Biologics Market: Distribution Channel
- 7.1.1. Global Retinal Biologics Market Revenue, by Distribution Channel, 2018 and 2025
- 7.2. Retail Sales
- 7.2.1. Global Retinal Biologics market for Retail Sales, 2017-2025 (USD Million)
- 7.3. Institutional Sales
- 7.3.1. Global Retinal Biologics market for Institutional Sales, 2017-2025 (USD Million)
- 7.1. Global Retinal Biologics Market: Distribution Channel
- Chapter 8. Global Retinal Biologics Market - Regional Analysis
- 8.1. Global Retinal Biologics Market: Regional Overview
- 8.1.1. Global Retinal Biologics Market Revenue, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.2.2. North America Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.2.3. North America Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.2.4.2. The U.S. Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.2.4.3. The U.S. Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.2.5.2. Rest of North America Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.2.5.3. Rest of North America Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.3.2. Europe Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.3.3. Europe Retinal Biologics Market Revenue, by End -User, 2017-2025 (USD Million)
- 8.3.4. UK
- 8.3.4.1. UK Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.3.4.2. UK Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.3.4.3. UK Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.5. Germany
- 8.3.5.1. Germany Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.3.5.2. Germany Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.3.5.3. Germany Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.3.6.2. France Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.3.6.3. France Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.3.7.2. Rest of Europe Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.3.7.3. Rest of Europe Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.4.2. Asia Pacific Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.4.3. Asia Pacific Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.4.4.2. China Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.4.4.3. China Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.4.5.2. Japan Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.4.5.3. Japan Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.4.6.2. India Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.4.6.3. India Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.5.2. Latin America Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.5.3. Latin America Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.5.4.2. Brazil Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.5.4.3. Brazil Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Retinal Biologics Market Revenue, by Drug Class, 2017-2025 (USD Million)
- 8.6.2. The Middle East and Africa Retinal Biologics Market Revenue, by Indication, 2017-2025 (USD Million)
- 8.6.3. The Middle East and Africa Retinal Biologics Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.1. Global Retinal Biologics Market: Regional Overview
- Chapter 9. Company Profile
- 9.1. Janssen Biotech
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Drug Class portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Alimera Sciences
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Drug Class portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. F. Hoffmann-La Roche
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Drug Class portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Ocular Therapeutix
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Drug Class portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Genzyme Corporation
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Drug Class portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. UCBCares
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Drug Class portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. AbbVie
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Drug Class portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Allergan
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Drug Class portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Swedish Orphan Biovitrum
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Drug Class portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Genentech
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Drug Class portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. Bristol-Myers Squibb
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Drug Class portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.12. Bausch & Lomb
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Drug Class portfolio
- 9.12.4. Business strategy
- 9.12.5. Recent developments
- 9.1. Janssen Biotech
Table Of Figures
List of Figures
1. Market Research Process
2. Market Research Methodology
3. Global Retinal Biologics Market Revenue, 2017–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Retinal Biologics market attractiveness analysis, by Drug Class
6. Global Retinal Biologics market attractiveness analysis, by Indication
7. Global Retinal Biologics market attractiveness analysis, by Distribution Channel
8. Global Retinal Biologics Market: market attractiveness analysis, by region
9. Company market share analysis, 2019
10. Global Retinal Biologics market revenue share by Drug Class, 2018 and 2025
11. Global Retinal Biologics market revenue share by TNF-α inhibitor, 2017–2025 (USD Million)
12. Global Retinal Biologics market revenue share by VEGF-A antagonist, 2017–2025 (USD Million)
13. Global Retinal Biologics market revenue share by Indication, 2018 and 2025
14. Global Retinal Biologics market revenue share by Diabetic Retinopathy, 2017–2025 (USD Million)
15. Global Retinal Biologics market revenue share by Macular Degeneration, 2017–2025 (USD Million)
16. Global Retinal Biologics market revenue share by Uveitis, 2017–2025 (USD Million)
17. Global Retinal Biologics market revenue share by Diabetic Macular Edema, 2017–2025 (USD Million)
18. Global Retinal Biologics market revenue share by Others, 2017–2025 (USD Million)
19. Global Retinal Biologics market revenue share by Distribution Channel, 2018 and 2025
20. Global Retinal Biologics market revenue share by Retail Sales, 2017–2025 (USD Million)
21. Global Retinal Biologics market revenue share by Institutional Sales, 2017–2025 (USD Million)
Table Of Tables
List of Tables
1. Global Retinal Biologics Market: Snapshot
2. Drivers of the Global Retinal Biologics Market: Impact Analysis
3. Restraints of the Global Retinal Biologics Market: Impact Analysis
4. North America Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
5. North America Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
6. North America Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
7. The U.S. Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
8. The U.S. Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
9. The U.S. Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
10. Rest of North America Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
11. Rest of North America Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
12. Rest of North America Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
13. Europe Global Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
14. Europe Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
15. Europe Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
16. U.K. Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
17. U.K. Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
18. U.K. Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
19. Germany Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
20. Germany Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
21. Germany Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
22. France Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
23. France Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
24. France Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
25. Rest of Europe Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
26. Rest of Europe Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
27. Rest of Europe Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
28. Asia Pacific Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
29. Asia Pacific Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
30. Asia Pacific Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
31. China Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
32. China Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
33. China Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
34. Japan Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
35. Japan Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
36. Japan Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
37. India Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
38. India Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
39. India Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
40. Rest of Asia Pacific Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
41. Rest of Asia Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
42. Rest of Asia Pacific Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
43. Latin America Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
44. Latin America Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
45. Latin America Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
46. Brazil Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
47. Brazil Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
48. Brazil Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
49. Rest of Latin America Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
50. Rest of Latin America Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
51. Rest of Latin America Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
52. The Middle East and Africa Retinal Biologics Market Revenue, by Drug Class, 2017–2025 (USD Million)
53. The Middle East and Africa Retinal Biologics Market Revenue, by Indication, 2017–2025 (USD Million)
54. The Middle East and Africa Retinal Biologics Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Retinal biologics are a class of medications derived from living organisms that are used to treat various retinal diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.
According to study, the Retinal Biologics Market size was worth around USD 24.79 billion in 2023 and is predicted to grow to around USD 49.56 billion by 2032.
The CAGR value of Retinal Biologics Market is expected to be around 8.00% during 2024-2032.
Europe has been leading the Retinal Biologics Market and is anticipated to continue on the dominant position in the years to come.
The Retinal Biologics Market is led by players like Janssen Biotech, Alimera Sciences, F. Hoffmann-La Roche, Ocular Therapeutix, Genzyme Corporation, UCBCares, AbbVie, Allergan, Swedish Orphan Biovitrum, Genentech, Bristol-Myers Squibb, and Bausch & Lomb.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed